Bank of Montreal’s HilleVax HLVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-58,834
Closed -$85.3K 3616
2025
Q1
$85.3K Buy
58,834
+23,071
+65% +$42.6K ﹤0.01% 2954
2024
Q4
$74K Buy
35,763
+11,459
+47% +$21.5K ﹤0.01% 3027
2024
Q3
$42.8K Buy
+24,304
New +$62.3K ﹤0.01% 3440
2023
Q4
Sell
-78,000
Closed -$1.23M 4122
2023
Q3
$1.23M Buy
+78,000
New +$1.1M ﹤0.01% 1940

Other funds holding HLVX

Bank of Montreal's HLVX Position: Q2 2025 in Review

Bank of Montreal sold out of HilleVax (HLVX) in Q2 2025, closing a stake of 58,834 shares — an estimated $85.3K sold.

Bank of Montreal first reported a position in HLVX in Q3 2023 and held it in 4 quarters. The position peaked at $1.23M in Q3 2023. 74 funds tracked by Wall St. Rank hold HLVX as of Q2 2025.

  • Bank of Montreal reported no remaining HilleVax position as of Q2 2025 after selling out during the quarter.
  • Bank of Montreal sold 58,834 HilleVax shares in Q2 2025, an estimated $85.3K.
  • Bank of Montreal first reported a position in HilleVax in Q3 2023 and held it in 4 quarters.
  • Bank of Montreal's HilleVax position peaked at $1.23M in Q3 2023.
  • 74 funds tracked by Wall St. Rank held HilleVax as of Q2 2025.

Based on Bank of Montreal's 13F filing for Q2 2025, filed 5 Aug 2025.